PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Autolus Limited, The MediaWorks, London, United Kingdom.\', \'National Institute for Biological Standards and Controlgrid.70909.37, Herts, United Kingdom.\', \'Division of Infection and Immunity, University College Londongrid.83440.3b, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/JVI.00685-21
?:doi
?:hasPublicationType
?:journal
  • Journal of virology
is ?:pmid of
?:pmid
?:pmid
  • 34287040
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.853
?:rankingScore_hIndex
  • 268
is ?:relation_isRelatedTo_publication of
?:title
  • Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all